Literature DB >> 18620121

Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study.

Hyun J Kim1, Gang Li, David Gjertson, Robert Elashoff, Sumit K Shah, Robert Ochs, Fah Vasunilashorn, Fereidoun Abtin, Matthew S Brown, Jonathan G Goldin.   

Abstract

RATIONALE AND
OBJECTIVES: Computerized classification techniques have been developed to offer accurate and robust pattern recognition in interstitial lung disease using texture features. However, these techniques still present challenges when analyzing computed tomographic (CT) image data from multiprotocols because of disparate acquisition protocols or from standardized, multicenter clinical trials because of noise variability. Our objective is to investigate the utility of denoising thin section CT image data to improve the classification of scleroderma disease patterns. The patterns are lung fibrosis (LF), groundglass (GG), honeycomb (HC), or normal lung (NL) within small regions of interest (ROIs).
METHODS: High-resolution CT images were scanned in a multicenter clinical trial for the Scleroderma Lung Study. A thoracic radiologist contoured a training set (38 patients) consisting of 148 ROIs with 46 LF, 85 GG, 4 HC, and 13 NL patterns and contoured a test set (33 new patients) consisting of 132 ROIs with 44 LF, 72 GG, 4 HC, and 12 NL patterns. The corresponding CT slices of a contoured ROI were denoised using Aujol's mathematic partial differential equation algorithm. The algorithm's noise parameter was estimated as the standard deviation of grey-level signal (in Hounsfield units) in a homogeneous, non-lung region: the aorta. Within each contoured ROI, every pixel within a 4 x 4 neighborhood was sampled (4 x 4 grid sampling). All sampled pixels from a contoured ROI were assumed to be the same disease pattern as labeled by the radiologist. 5,690 pixels (3,009 LF, 1,994 GG, 348 HC, and 339 NL) and 5,045 pixels (2,665 LF, 1,753 GG, 291 HC, and 336 NL) were sampled in training and test sets, respectively. Next, 58 texture features from the original and denoised image were calculated for each pixel. Using a multinomial logistic model, subsets of features (one from original and another from denoised images) were selected to classify disease patterns. Finally, pixels were classified into disease patterns using a support vector machine procedure.
RESULTS: From the training set, multinomial logistic model selected 45 features from the original images and 38 features from denoised images to classify disease patterns. Using the test set, the overall pixel classification rate by SVM increased from 87.8% to 89.5% with denoising. The specific classification rates (original/denoised) were 96.3/96.4% for LF, 88.8/89.4% for GG, 21.3/28.9% for HC, and 73.5/88.4% for NL. Denoising significantly improved the NL and overall classification rates (P = .037 and P = .047 respectively) at ROI level.
CONCLUSIONS: Analyzing multicenter data using a denoising approach led to more parsimonious classification models with increasing accuracy. This approach offers a novel alternate classification strategy for heterogeneous technical and disease components. Furthermore, the model offers the potential to discriminate the multiple patterns of scleroderma disease correctly.

Entities:  

Mesh:

Year:  2008        PMID: 18620121      PMCID: PMC2584616          DOI: 10.1016/j.acra.2008.03.011

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  15 in total

Review 1.  AAPM/RSNA Physics Tutorial for Residents: Topics in CT. Radiation dose in CT.

Authors:  Michael F McNitt-Gray
Journal:  Radiographics       Date:  2002 Nov-Dec       Impact factor: 5.333

2.  Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment.

Authors:  Alan C Best; Anne M Lynch; Carmen M Bozic; David Miller; Gary K Grunwald; David A Lynch
Journal:  Radiology       Date:  2003-06-11       Impact factor: 11.105

3.  Quantitative CT of fibrotic interstitial lung disease.

Authors:  David A Lynch
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

4.  Support vector machines for histogram-based image classification.

Authors:  O Chapelle; P Haffner; V N Vapnik
Journal:  IEEE Trans Neural Netw       Date:  1999

5.  Computer recognition of regional lung disease patterns.

Authors:  R Uppaluri; E A Hoffman; M Sonka; P G Hartley; G W Hunninghake; G McLennan
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

6.  Computer-aided lung nodule detection in CT: results of large-scale observer test.

Authors:  Matthew S Brown; Jonathan G Goldin; Sarah Rogers; Hyun J Kim; Robert D Suh; Michael F McNitt-Gray; Sumit K Shah; Dao Truong; Kathleen Brown; James W Sayre; David W Gjertson; Poonam Batra; Denise R Aberle
Journal:  Acad Radiol       Date:  2005-06       Impact factor: 3.173

Review 7.  Idiopathic interstitial pneumonias: CT features.

Authors:  David A Lynch; William D Travis; Nestor L Müller; Jeffrey R Galvin; David M Hansell; Philippe A Grenier; Talmadge E King
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

8.  Obstructive lung diseases: texture classification for differentiation at CT.

Authors:  Francois Chabat; Guang-Zhong Yang; David M Hansell
Journal:  Radiology       Date:  2003-07-17       Impact factor: 11.105

Review 9.  High resolution lung computed tomography. Normal anatomic and pathologic findings.

Authors:  W R Webb
Journal:  Radiol Clin North Am       Date:  1991-09       Impact factor: 2.303

10.  Characterization of digital medical images utilizing support vector machines.

Authors:  Ilias G Maglogiannis; Elias P Zafiropoulos
Journal:  BMC Med Inform Decis Mak       Date:  2004-03-10       Impact factor: 2.796

View more
  25 in total

1.  Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.

Authors:  Elizabeth R Volkmann; Donald P Tashkin; Myung Sim; Ning Li; Ellen Goldmuntz; Lynette Keyes-Elstein; Ashley Pinckney; Daniel E Furst; Philip J Clements; Dinesh Khanna; Virginia Steen; Dean E Schraufnagel; Shiva Arami; Vivien Hsu; Michael D Roth; Robert M Elashoff; Keith M Sullivan
Journal:  Ann Rheum Dis       Date:  2018-11-08       Impact factor: 19.103

2.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

3.  Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.

Authors:  Jonathan G Goldin; Grace Hyun J Kim; Chi-Hong Tseng; Elizabeth Volkmann; Daniel Furst; Philip Clements; Matt Brown; Michael Roth; Dinesh Khanna; Donald P Tashkin
Journal:  Ann Am Thorac Soc       Date:  2018-11

4.  A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.

Authors:  H G Kim; D P Tashkin; P J Clements; G Li; M S Brown; R Elashoff; D W Gjertson; F Abtin; D A Lynch; D C Strollo; J G Goldin
Journal:  Clin Exp Rheumatol       Date:  2010-11-03       Impact factor: 4.473

5.  Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.

Authors:  Suparaporn Wangkaew; Juntima Euathrongchit; Pittaporn Wattanawittawas; Nuntana Kasitanon
Journal:  Quant Imaging Med Surg       Date:  2016-08

6.  Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.

Authors:  Hyun J Kim; Matthew S Brown; Robert Elashoff; Gang Li; David W Gjertson; David A Lynch; Diane C Strollo; Eric Kleerup; Daniel Chong; Sumit K Shah; Shama Ahmad; Fereidoun Abtin; Donald P Tashkin; Jonathan G Goldin
Journal:  Eur Radiol       Date:  2011-09-17       Impact factor: 5.315

7.  Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.

Authors:  Elizabeth R Volkmann; Donald P Tashkin; Myung Sim; Ning Li; Dinesh Khanna; Michael D Roth; Philip J Clements; Anna-Maria Hoffmann-Vold; Daniel E Furst; Grace Kim; Jonathan Goldin; Robert M Elashoff
Journal:  J Rheumatol       Date:  2019-02-15       Impact factor: 4.666

Review 8.  Imaging lung disease in systemic sclerosis.

Authors:  Diane Strollo; Jonathan Goldin
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

9.  Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease.

Authors:  Elizabeth R Volkmann; Donald P Tashkin; Ning Li; Daniel E Furst; Philip J Clements; Robert M Elashoff
Journal:  Rheumatology (Sunnyvale)       Date:  2015-06-30

10.  Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.

Authors:  Jonathan Goldin; Robert Elashoff; Hyun J Kim; Xaiohong Yan; David Lynch; Diane Strollo; Michael D Roth; Philip Clements; Daniel E Furst; Dinesh Khanna; Srainnapha Vasunilashorn; Gang Li; Donald P Tashkin
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.